Avanza Fonder Ab Mereo Biopharma Group PLC Transaction History
Avanza Fonder Ab
- $3.05 Trillion
- Q1 2025
A detailed history of Avanza Fonder Ab transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Avanza Fonder Ab holds 28,121 shares of MREO stock, worth $70,302. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,121
Previous 19,600
43.47%
Holding current value
$70,302
Previous $68.6 Million
2.85%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MREO
# of Institutions
97Shares Held
117MCall Options Held
199KPut Options Held
450K-
Janus Henderson Group PLC London, X017.1MShares$42.8 Million0.03% of portfolio
-
Rubric Capital Management LP New York, NY15.3MShares$38.3 Million0.99% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.6MShares$24 Million1.34% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.72MShares$21.8 Million0.06% of portfolio
-
Mangrove Partners New York, NY8.64MShares$21.6 Million4.71% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $312M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...